mf ...... Dow Jones up +423.45

Don't want to post?

I will do it for you mf.

Breakwind tax will be tabled in Budget as opposed to Windfall tax. lol.

So don't get spooked by the sick rumour.

Why kill the Golden Gloves/Goose?

Breaking news- Global shortfall of more than 200 billion.
------------------------------------------------------
By Laura Strickler, Stephanie Gosk, Lisa Cavazuti and Brenda Breslauer

The Trump administration was slow to take action amid a mounting shortage of medical gloves, experts said, setting in motion a scramble to stockpile the crucial personal protective equipment as Covid-19 rampages across the country.

The synthetic rubber “nitrile” gloves are a critical barrier to infection for health care workers on the front lines, but experts say the United States is poorly positioned to get ahead of a global shortfall of more than 200 billion.

The Strategic National Stockpile, which is supposed to be the source of last resort after hospitals have exhausted their supplies, is running dangerously low on gloves amid soaring demand across the country.

Supermax PE Explosion?- Its a matter of time Folks.

Author: omione


I'm increasingly coming across articles cautioning us that we may *never* have a vaccine against Covid-19 even as we are fast approaching the moment with hopeful anticipation that a number of vaccines in stage III of trial will soon announce their findings. Against the backdrop of the historical developments of vaccines, the odds of developing a covid-19 vaccine this fast - within such a short timeframe - are realistically close to nil.

So what if the vaccines are not as successful as we hope for come December 2020? If all the vaccines currently undergoing stage III trials fail, it will have a significant long-term impact on the stock price of Supermax.

First, there will be further shift of demand curve to the right within a fairly short period of time. What this means is that many countries and industries that are not using disposable gloves will start adopting the practice of wearing gloves on a routine basis. Such exponential demand growth will not be met even by the production capacity expansions currently being undertaken, putting further pressure on ASP.

Second, Supermax PE valuation will explode. Supermax earnings have been growing exponentially for the last 3 quarters. Yet, the market is not valuing it as a growth stock. Annualizing the Supermax's PE based on the last quarter's EPS (30.58 sen x 4), the market is valuing Supermax stock price at a pathetic 7.7X. This is worse than PEs valuing companies with declining earnings. Why? Some speculate that it is the results of Investment Bankers suppressing Supermax stock price to mitigate their structured warrant losses. There may have some truth in that. But more probably, the market, rightly or wrongly, perceive that Supermax's super earnings growth is unsustainable. The pandemic will soon be eradicated. Demands for gloves will regress to pre-covid levels. ASP will fall. Supermax's exponential earnings growth will dissipate. I personally believe that such perceptions are flawed. But who is to argue with Mr. Market? So once these misconceptions are unequivocally exposed by the failed vaccine trials, Supermax's PE will explode to 40X or 50X. (Unimaginable? PE for Tesla is 1,000+X.)

In conclusion, Supermax stock is HUGELY UNDERVALUED. Demands for gloves are inelastic. We all know that Supermax's earnings are still growing - vaccine or no vaccine. Earnings are far from peaking. The earnings growth is recession-proof. We just need to wait for Mr. Market to catch up. When (not 'if') that happens, there will be a stampede for Supermax shares.

Physicians warn that a vaccine may not prevent Covid from becoming endemic
-----------------------------------------------------------------------
KEY POINTS
“I think the answer is that, yes, this will become endemic,” said Dr. David Heymann, who led the WHO’s infectious disease unit during the SARS epidemic in 2002-2003.

This means the infection rate of the coronavirus, like other coronaviruses, may eventually stabilize at a constant level and become present in communities at all times.

To protect yourself, the WHO recommends that people keep a distance of at least 1 meter from others and disinfect frequently touched surfaces. It also advises cleaning hands thoroughly and often, and for people to avoid touching their eyes, mouth and nose.

Global shortfall of more than 200 billion.
----------------------------------------
Trump admin is 'woefully behind' in stockpiling medical gloves as Covid-19 surges
Nitrile gloves are critical for frontline medical workers, but experts say the U.S. is poorly positioned to get ahead of a global shortfall of more than 200 billion.

Final dividend via share dividend distribution on the basis of one (1) treasury share for every forty-five (45) existing ordinary shares held in the Company in respect of the financial year ended 30 June 2020.

Ex-Date07 Dec 2020

SUPERMAX is the best stock in Bursa.

A SUPER stock .

Fully agree @frank74

1) has been consolidating for 3 months...
2) trailing PE has reduced to 20x in that time
3) still a few quarters of phenomenal numbers to come

and you guys want to sell?! Good luck with sellers remorse

Supermax is lacking from large institutional FUNDS.
------------------------------------------
Fully agree and absolutely True. This will happen when SUPERMAX is admitted to the KLCI index in mid December.

It should do well if 2-3 large long term investor takes up between 10%-15% each would provide long term price sustainability.

Probably by year end when KLCI components are reviewed, funds would normally invest in index link companies.

SUPER TO THE MAX
--------------------
Pressing the price incessantly is not sustainable- It will be an exercise in futility especially with the likes of grossly undervalued GEMs like Supermax.

It will ultimately rise to reflect its FANTASTIC fundamentals.

INVEST in this GEM to maximise profits & IGNORE the CLOWNS.

Ups and downs will always appear from time to time.

SUPERMAX will always be the SUPER STOCK.

Supermax Corporation Berhad- Grab while it's still severely Undervalued.
------------------------------
(7106 | SUCB MK) | Health Care| Health Care Equipment & Services

Growing global ambition

KEY INVESTMENT HIGHLIGHTS

 1QFY21 earnings beat expectations
 1QFY21 net profit up by 98.3%qoq to RM793.5m
 Still room for ASP growth
 Plans to build plants overseas
 Eyeing dual listing in Singapore
 Maintain BUY with an unchanged TP RM15.

investors should consider switching t0 SUPERMAX-
--------------------------------------------------
HARTA only made 220 million last quarter.
SUPERMX made 400 million last quarter.

Now, SUPERMAX did 800 million but
HARTA only did RM550 million.

Harta's market cap is TWO TIMES larger than Supermax, but Supermax beats Harta's profits by a mile.

Come December SUPER will SKYROCKET as it will be included in the KLCI Composit index. By then SUPER will catch up with HARTA.

A TP of RM15 is not a problem by end of year.

The best GLOVE counter in BURSA.

Long term SUPERMAX investors are the biggest winners.

Hold on to this GEM.

Correct Bro Alan
----------------
Guys guyss, no point argueing the share price is going up or going down. In the long run SUPER will be flying to the moon. So if u like it, then buy, if u dont then just keep quiet and watch the flight.

Most importantly is holding power, if u are buying glove. Just buy and hold, it will definitely give u better returns than the FD in the bank.

GLOVES, the most profitable sector to be in.

Other sectors will be fighting for survival.

Just be patient.

Mah Sing Group - A Valuable Venture
-------------------------------------
Mah Sing’s venture into the gloves business is timely as it diversifies its earnings base from being reliant towards the property market which is experiencing a slowdown. Ideally, Mah Sing would be able to tap onto its expertise and know-how of its regional plastics business in order to synergize with this potential venture.

“Our first glove factory is ready and it is ultra-long to accommodate modern, high speed machines which can run at a speed of 38,000 pieces of gloves per production line per hour, ” said Mah Sing founder and group managing director Tan Sri Leong Hoy Kum.

Mah Sing Group Bhd is set to commence glove production in April 2021. Mah Sing has commenced additional piling works that is expected to be completed by November 2020, to be immediately followed by installation of the machinery. These 12 production lines are Phase 1 of Mah Sing’s diversification into gloves and have a maximum production capacity of up to 3.7bn pieces of gloves per annum. (The Edge)

Fully agree !

Careplus s (3rdQ'2020) s PAT almost same ~ comfort s $42.8mil
Year Roll over 4quoter : e.p.s at 15.06cts > comfort s 13.22cts
Share price as on 23.10.2020 : $3.78 < comforts s $4.30
Net profit margin by 23.2% > comfort s 16.8%


Careplus s production capacity escalating amazingly,
from currently 4.62bil. pcs glove to 10.5 bil by end of 2021 .

Am impress with curiosity to see Careplus vs Mahsing;
who shall has stronger muscle to conquer the 6th or perhaps 5th Biggest glove producer title in 2021 ?


MY CONCLUSION
Careplus should worth an immediately re-rating FV at ($6.76 / share)

Thank you !

Glove supply will not meet demand in next three years, says Hartalega chairman
---------------------------------------------------------------
theedgemarkets.com

The supply of the rubber gloves will not be able to meet the demand in the next three years, said Hartalega Holdings Bhd executive chairman Kuan Kam Hon.

“Right now, there is an enormous shortage (due to the pandemic)... We do not even know whether we (the industry) have enough to meet the demand for 120 billion more pieces of gloves in the next three years,” he said.

Mah Sing - New Kid on the block
Author: lkpiew | Publish date: Thu, 22 Oct 2020, 9:32 PM

Mah sing is know for its property development, (normally comes with construction cababilities) but less known for its plastic business. To get the hardware up and running is easy for MS, from drawing to construction and handover of a factory, is what they are good at, to get the machineries and raw material is also not difficult....what is the main part is the right people to get the job done.

MS mentioned that they have appointed Team armed with 30 yers of experience in the Glove sector.

Sales network ? does MS has the right sales channel ? can they command the same ASP as the othe big 4? may be not ! but given the supply shortage, a good reasonable ASP could be expected.....!!!from the future production capacity, any i3 follower should be able to calculate the future QTR earning and PE and TP...yes, MS is not making good money in the last many QTR, in fact not my investment target so far.

Share investment is all about future, historical data is only for reference and does not guarantee the future performance (sounds familiar right ?) if you believe MS will get the production line up and running, then make up your mind as well.

The big 4 gloves and the existing small 4, their prices are in fact forward prices, those expert on the i3 knows them by heart, invest for tomorrow, the passed qtr results are just the indicators of the passed, as they believe the pass will repeat in the future, (at least the next imminent qtr), therefore look FORWARD.

If MS does provide any indicator (indicator out of those usual financial indicator like PE, PAT or ROI etc) that the golves production is imminent......then look FORWARD.

It might not be the last to jump into the glove rush, but out of the handfull, this new kid does make my head turn.

Careplus will be reporting an impressive PAT later today.

My estimate is a PAT of RM40 mil and a TP of RM4.80.

‘Learn to live with the pandemic’:

Physicians warn that a vaccine may not prevent Covid from becoming endemic https://www.cnbc.com/2020/10/22/coronavirus-physicians-warn-virus-may-become-endemic-despite-vaccine.html Dr. David Heymann, who led the WHO’s infectious disease unit during the SARS epidemic in 2002-2003, believes some governments may be over-reliant on the development of a vaccine at a time when effective communication, diagnostic testing and outbreak containment activities are all critically important tools. “The difficulty right now is that in many countries, they are looking forward to a vaccine which may or may not come, which may or may not be effective in the short or long term, and they are looking at possible therapeutic (options) which could solve many of the problems,” Heymann said Wednesday during a webinar for think tank Chatham House. “But, that’s not a good way to proceed at present. … We have to learn to live with the pandemic.”

MAH SING is a GEM not a SCAM.

Mah Sing has the expertise, experience and financial strength to make it HUGE success -

TS Leong is passionate about Gloves and is so determined to Prove many Critics especially Uncle KY dead WRONG.

Just accumulate MAH and SING all the way to the bank.

Very interesting article-

https://klse.i3investor.com/blogs/lkp/

Very interesting article-

https://klse.i3investor.com/blogs/lkp/

Very interesting article

https://klse.i3investor.com/blogs/lkp/

Mah Sing- A New Kid On The Block- A Rising Star

Very interesting article- A must read for MS investors.

https://klse.i3investor.com/blogs/lkp/

Mah Sing- A New Kid On The Block- A Rising Star

Very interesting article- A must read for MS investors.

https://klse.i3investor.com/blogs/lkp/

Mah Sing- A New Kid On The Block- A Rising Star

Very interesting article- A must read for MS investors.

https://klse.i3investor.com/blogs/lkp/

Mah Sing- A New Kid On The Block- A Rising Star

Very interesting article- A must read for MS investors.

https://klse.i3investor.com/blogs/lkp/

MS is considered a high growth healthcare stock due to its diversification to Glove production. Its financial strength, passionate management & vast experience in manufacturing will definitely make it a profitable venture. With its foray in to Gloves , MS is fairly valued at Rm2.50. This is a stock that is not to be missed. Just buy and hold and you will be amply rewarded. Of course to journey towards its fair value won't be plain sailing.

Naysayers and short term traders will always be hanging around here like pesky mosquitos with their own agenda. Don't whack them, just ignore them.

Always do your homework before diving in to a stock.

MS may turn out to be a GEM.

Massive buying at close.
----------------------
A massive 15 million MS shares changed hands at close today at RM1.14- following a 2 sen gap up in TO price.

Another gap up in opening price tomorrow morning is imminent.

Yup. more horse power required tomorrow- to maintain the uptrend.

“Our first glove factory is ready and it is ultra-long to accommodate modern, high speed machines which can run at a speed of 38,000 pieces of gloves per production line per hour, ” said Mah Sing founder and group managing director Tan Sri Leong Hoy Kum.

Brazilian President Jair Bolsonaro on Wednesday rejected the announced purchase of 46 million doses of a potential vaccine against the coronavirus being developed by a Chinese company.
-----------------------------------------------
“The Brazilian people will not be anyone’s guinea pig,” Bolsonaro said on his social media channels, adding that the vaccine has not yet completed testing, which is the case with all potential vaccines for the virus. “My decision is to not purchase such a vaccine.”

Latest news on Vaccines
------------------------
AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue

By Eduardo Simões, Ludwig Burger
OCTOBER 22

SAO PAULO/FRANKFURT (Reuters) - Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca AZN.L and Oxford University had died but added that the trial would continue.

Mah Sing Group Bhd is set to commence glove production in April 2021. Mah Sing has commenced additional piling works that is expected to be completed by November 2020, to be immediately followed by installation of the machinery. These 12 production lines are Phase 1 of Mah Sing’s diversification into gloves and have a maximum production capacity of up to 3.7bn pieces of gloves per annum. (The Edge)

Source: Mplus Research - 22 Oct 2020

Mah Sing is a respectable company- a quality and financially strong company with top class management. This is not a lap sap company.

TS Leong is a honourable man. He won't let you down. It takes years to build good reputation as he did for MS.

Would he just cakap kosong and risk the good reputation going down the drain?

Best is to study the company first before you investing in it- then decide.

I believe MS will do well in GLOVES.

SUPERmax is the stock to hold if you are a serious INVESTOR as its fundamentals keep getting stronger with each passing day. Correction or rather profit taking will occur from time to time- its normal- absolutely nothing to worry.

SUPERmax's brilliant business model OBM+ODN=SUPER PROFITS- will make it the most profitable GLOVE stock among the BIG 4.

The outlook is bright as experts say that Covid is Endemic- The Dictionary of Epidemiology defines an endemic disease as “the constant presence of a disease"- meaning COVID will not go away and sadly , we have to live with it for a long time with or without a vaccine.

Stay focussed and be patient with this SUPER stock.

That's a great song @ Joyvest- By Neil Diamond.

MS Healthcare will be Professionally Managed
------------------------------------------
TS Leong said Mah Sing’s glove business will be primarily be managed by a professional team with experience in glove manufacturing.

He said Mah Sing will be able to tap into the expertise and know-how of its regional plastics business in order to synergize with the gloves business.

No worries. The Horse always delivers and sings as well.

MS Healthcare BULLISH on BUYERS
-------------------------
The property developer said that at this juncture, Mah Sing Healthcare Sdn Bhd has secured letters of intent from several prospective customers and the cumulative indicative orders have already exceeded the estimated maximum capacity for both phases of the Kapar factory.

If demand permits, Mah Sing Healthcare will gradually expand up to 100 production lines as part of future expansion plans, it said.

FAST TURNAROUND BUSINESS MODEL- TO PROVE THE SKEPTICS WRONG
---------------------------------------------------------------------
Mah Sing founder and group managing director Tan Sri Leong Hoy Kum said similar to its property development’s fast turnaround business model, the firm is fast-tracking its diversification into gloves.

“We have also secured supply of both nitrile-butadiene rubber and latex raw materials, and should be able to quickly meet [the] demand of our customers.

“We are targeting production by as early as April 2021,” said Leong.

Tan Sri Leong's new found passion ie GLOVES.

BREAKING NEWS
------------------------
Mah Sing Group Bhd is set to commence glove production in April 2021.

KUALA LUMPUR (Oct 21):

In a statement today, Mah Sing said it has commenced additional piling works to accommodate 12 units of new, high-speed glove dipping machines at its glove manufacturing factory in Kapar, Klang, to meet its targeted production date.

It said the piling works are expected to be completed by November 2020, to be immediately followed by installation of the machinery.

These 12 production lines are Phase 1 of Mah Sing’s diversification into gloves and have a maximum production capacity of up to 3.68 billion pieces of gloves per annum.

Mah Sing founder and group managing director Tan Sri Leong Hoy Kum said similar to its property development’s fast turnaround business model, the firm is fast-tracking its diversification into gloves.

He said the factory has a suitable roof height to house mega machines.

“We have also secured supply of both nitrile-butadiene rubber and latex raw materials, and should be able to quickly meet [the] demand of our customers.

“We are targeting production by as early as April 2021,” said Leong.

Leong said Mah Sing’s glove business will be primarily be managed by a professional team with experience in glove manufacturing.

He said Mah Sing will be able to tap into the expertise and know-how of its regional plastics business in order to synergize with the gloves business.

With a build-up of approximately 228,800 sq ft, the current factory is Phase 1 of Mah Sing’s new foray into glove manufacturing.

Fabrication works for the new machinery have already started at the equipment supplier’s factory, and installation of the initial lines is expected to commence in November 2020; the first six production lines are expected to be ready for operation as early as the second quarter of 2021 (2Q21), followed by another six production lines by 3Q21.

Mah Sing is targeting a second phase of the expansion plan, which includes exercising the option to take up the other portion of the Kapar factory (build-up of approximately 287,500 square feet).

This could accommodate another 12 new production lines and increase the capacity up to another 3.68 billion pieces of gloves per annum. The Phase 2 expansion is targeted to happen when demand outstrips supply for Phase 1.

The property developer said that at this juncture, Mah Sing Healthcare Sdn Bhd has secured letters of intent from several prospective customers and the cumulative indicative orders have already exceeded the estimated maximum capacity for both phases of the Kapar factory.

If demand permits, Mah Sing Healthcare will gradually expand up to 100 production lines as part of future expansion plans, it said.

Correct!, catch or rather accumulate it when its low.

Coronavirus likely to become as ‘endemic’ as flu-Vaccine might not be able to stop it.
--------------------------------------------

Coronavirus likely to become as ‘endemic’ as the flu and a vaccine might not be able to stop it, top UK scientist says

Covid-19 is likely to become as “endemic” as the annual flu virus, according to the U.K.’s chief scientific advisor.

A vaccine is not likely to eradicate the virus, the advisor cautioned.

Thats why MS diversified in to GLOVES. Demand will be strong for many many years.

Mah Sing has the financial strength to venture into the glove manufacturing business given its current strong cashflow position coupled with the new issuance of RM100mil convertible sukuk. After paying RM150mil capex for phase 1, Mah Sing’s net gearing will increase from 0.4% to 4.8%. All in all, we see this is a positive move by the management given the good prospects in glove business amid the covid19 pandemic. We believe the demand of glove will remain stable post-covid19 due to increase in healthcare awareness and more stringent regulations. We maintain our BUY recommendation on Mah Sing with a fair value of RM1.50.

Source: AmInvest Research -

MS glove making division will lead by a management team with more than 30 years of experience in the glove industry. Mah Sing intends to gradually expand up to 100 gloves production lines as part of the group’s future expansion plan.

Yup, MS can always hire the best for success.

KUALA LUMPUR (Oct 20): The main index at Bursa Malaysia pared some of its loss at the midday break today, against the backdrop of weaker regional markets on US election question marks, while Mah Sing Group Bhd looks to be fast emerging as the new darling of investors.

Mah Sing Group - A Valuable Venture
---------------------------------
MS is a Financially strong entity and has vast experience from manufacturing to construction. They are so well connected in the business world so much so that they plan to put up a factory in less than a year. If you have the expertise I don't see why not.

By the way it is via a conversion from a massive warehouse to a Glove factory in Klang. No worries no piling work involved. Its mainly refurbishment.

The company's background and the people behind is of utmost importance before investing in them. With over 40 years in manufacturing & top 5 property developer in Malaysia I certainly believe that their diversification in to Gloves will be a roaring success.

MS also received numerous accolades in the property sector.

Sad that Uncle Koon chose to criticised MS without basis.

He probably collected a lot today. Congrats Uncle.

@morpheous should be interested in the new Call Warrant

Apologies Bro Morphy just a joke.
---------------------------------
Posted by i3gambler > Oct 20, 2020 7:36 PM | Report Abuse

https://klse.i3investor.com/blogs/gambler/2020-10-20-story-h1534737887...

New SUPERMX Call Warrant to be listed tomorrow.

MS surged from 72 sen to rm1.47 is a 3 day steep climb, a slight pullback is much welcomed before resuming its uptrend.

The good news is that market accepting MS as a glove counter- the best sector to be in currently.

Healthy correction for MS, uptrend to resume tomorrow.

Just ride the wave

Rm 2-00 -short term target